Zerbaxa 1.5 gram vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQU2N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,952
Award facts
- Contract value 100% obligated
- $37,952.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,952.03 to AmerSourceBergen Drug Corp for 1.5 gram vials of Zerbaxa, an antibiotic medication used to treat bacterial infections in hospitalized patients. This non-competitive delivery order, issued on January 12, 2026, with completion targeted for January 13, 2026, represents a task order against AmerSourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems including military treatment facilities and veteran healthcare programs.
This delivery order falls under AmerSourceBergen's substantial $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally. The parent company, Cencora, Inc., also maintains a separate $999,999,999.00 IDC with the same agency through December 31, 2031. As a critical vendor in the federal pharmaceutical supply chain, AmerSourceBergen competes on a full and open basis without set-aside preferences and regularly fulfills orders for brand-name and generic medications across multiple therapeutic domains to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQU2N?
SPE2DR26FQU2N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU2N worth?
The government has obligated $37,952 on SPE2DR26FQU2N.
Is contract SPE2DR26FQU2N an order under another contract?
Yes. SPE2DR26FQU2N is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU2N competed?
The extent of competition for SPE2DR26FQU2N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award